Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-12-28

Clinical Trial Update: Norfloxacin Versus Ciprofloxacin for Spontaneous Bacterial Peritonitis (SBP) Prevention [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Norfloxacin to Ciprofloxacin for the prevention of spontaneous bacterial peritonitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ciprofloxacin (Ciprofloxacin hydrochloride)
  • Norfloxacin (Norfloxacin)

Snippet

Sponsor: Korea University | Conditions: Adverse Reaction to Other Drugs and Medicines | Phase 4 | Status: COMPLETED